Lapointe Anthony Gregg
Rigel Pharmaceuticals, Inc. · Director
Lapointe Anthony Gregg is listed in public filings as director. This Lapointe Anthony Gregg insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Rigel Pharmaceuticals, Inc. (RIGL), Astria Therapeutics, Inc. (ATXS), and Soligenix, Inc. (SNGX). Investors use Lapointe Anthony Gregg's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --18.3k shares | Grant / ExerciseMay 15, 2026 | Disclosure amount unavailable5.8k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $016.7k shares | OtherJan 23, 2026 | $204.0K16.7k shares | $12.24 | -- | |
| $014.1k shares | OtherJan 23, 2026 | $160.0K14.1k shares | $11.35 | -- | |
| $026.6k shares | OtherJan 23, 2026 | $153.7K26.6k shares | $5.79 | -- | |
| $014.1k shares | OtherJan 23, 2026 | $129.4K14.1k shares | $9.18 | -- | |
| $08.3k shares | OtherJan 23, 2026 | $25.0K8.3k shares | $3.00 | -- | |
| $30k17.6k shares | Grant / ExerciseJun 20, 2025 | $30.0K17.6k shares | $1.70 | -- | |
| $154k26.6k shares | Grant / ExerciseJun 11, 2025 | $153.7K26.6k shares | $5.79 | -- | |
| --12.5k shares | Grant / ExerciseMay 23, 2025 | Disclosure amount unavailable2.5k shares | -- | -- | |
| $57k3k shares | Grant / ExerciseMay 23, 2025 | $56.9K3k shares | $18.95 | -- | |
| $30k8.6k shares | Grant / ExerciseDec 12, 2024 | $30.0K8.6k shares | $3.47 | -- |